ADMA Biologics, Inc. (ADMA)
9.23
-0.16
(-1.70%)
USD |
NASDAQ |
Sep 11, 16:00
9.235
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price : 9.23 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 9.44 | 9.50 | 9.195 | 9.23 | 2.267M |
| Sep 10, 2026 | 9.39 | 9.50 | 9.33 | 9.39 | 2.831M |
| Sep 09, 2026 | 9.47 | 9.506 | 9.32 | 9.45 | 2.383M |
| Sep 08, 2026 | 9.51 | 9.65 | 9.41 | 9.54 | 1.993M |
| Sep 04, 2026 | 9.43 | 9.62 | 9.39 | 9.62 | 1.406M |
| Sep 03, 2026 | 9.52 | 9.60 | 9.345 | 9.58 | 1.326M |
| Sep 02, 2026 | 9.34 | 9.63 | 9.320 | 9.51 | 1.990M |
| Sep 01, 2026 | 9.38 | 9.505 | 9.29 | 9.33 | 1.756M |
| Aug 31, 2026 | 9.33 | 9.475 | 9.22 | 9.39 | 1.756M |
| Aug 28, 2026 | 9.46 | 9.51 | 9.34 | 9.34 | 1.838M |
| Aug 27, 2026 | 9.56 | 9.625 | 9.385 | 9.48 | 1.496M |
| Aug 26, 2026 | 9.70 | 9.72 | 9.535 | 9.63 | 1.371M |
| Aug 25, 2026 | 9.56 | 9.76 | 9.52 | 9.72 | 1.479M |
| Aug 24, 2026 | 9.80 | 9.912 | 9.535 | 9.55 | 1.963M |
| Aug 21, 2026 | 9.77 | 9.95 | 9.68 | 9.84 | 1.477M |
| Aug 20, 2026 | 9.98 | 10.08 | 9.695 | 9.76 | 2.193M |
| Aug 19, 2026 | 9.76 | 10.12 | 9.70 | 10.05 | 2.689M |
| Aug 18, 2026 | 9.35 | 9.579 | 9.335 | 9.54 | 1.370M |
| Aug 17, 2026 | 9.51 | 9.60 | 9.315 | 9.34 | 1.497M |
| Aug 14, 2026 | 9.47 | 9.49 | 9.33 | 9.47 | 1.309M |
| Aug 13, 2026 | 9.85 | 9.865 | 9.24 | 9.41 | 3.107M |
| Aug 12, 2026 | 9.83 | 9.96 | 9.755 | 9.78 | 1.919M |
| Aug 11, 2026 | 9.875 | 10.01 | 9.73 | 9.905 | 2.539M |
| Aug 10, 2026 | 9.79 | 10.06 | 9.705 | 9.75 | 1.899M |
| Aug 07, 2026 | 9.97 | 10.18 | 9.75 | 9.90 | 3.305M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Erasca, Inc. | 15.88 |
| Vericel Corp. | 38.34 |
| BioMarin Pharmaceutical, Inc. | 65.68 |
| Emergent BioSolutions, Inc. | 6.23 |
| Exelixis, Inc. | 56.12 |
Price Related Metrics
| PE Ratio | 13.10 |
| PS Ratio | 4.319 |
| Price to Book Value | 5.096 |
| Price to Free Cash Flow | 19.04 |
| Earnings Yield | 7.63% |
| Market Cap | 2.080B |
| Operating PE Ratio | 10.22 |
| Normalized PE Ratio | 12.99 |